Advertisement
Singapore markets closed

  • Straits Times Index

    3,296.89
    +4.20 (+0.13%)
     

  • S&P 500

    5,034.74
    +16.35 (+0.33%)
     

  • Dow

    38,053.56
    +150.27 (+0.40%)
     

  • Nasdaq

    15,697.72
    +92.24 (+0.59%)
     

  • Bitcoin USD

    58,766.89
    +1,307.52 (+2.28%)
     

  • CMC Crypto 200

    1,260.71
    -10.03 (-0.79%)
     

  • FTSE 100

    8,171.26
    +50.02 (+0.62%)
     

  • Gold

    2,304.80
    -6.20 (-0.27%)
     

  • Crude Oil

    79.05
    +0.05 (+0.06%)
     

  • 10-Yr Bond

    4.6310
    +0.0360 (+0.78%)
     

  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     

  • Hang Seng

    18,207.13
    +444.10 (+2.50%)
     

  • FTSE Bursa Malaysia

    1,580.30
    +4.33 (+0.27%)
     

  • Jakarta Composite Index

    7,117.42
    -116.77 (-1.61%)
     

  • PSE Index

    6,646.55
    -53.94 (-0.81%)
     

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2024

Business Wire
·1-min read

Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF’s General Regulations.

SOPHIA ANTIPOLIS, France, April 10, 2024--(BUSINESS WIRE)--Regulatory News:

Median Technologies (Paris:ALMDT):

Total number of shares

18,404,608

Number of real voting rights*
(excluding treasury shares**)

18,338,930

Theoretical number of voting rights*
(including treasury shares**)

18,296,452

(*) Class E preference shares are non-voting
(**) pursuant to article 223-11 of the AMF’s General Regulations

About Median Technologies: Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer diagnoses and cancer treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis™, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. The French-based company, with a presence in the U.S. and China, is listed on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240410892832/en/

Contacts

Median Technologies
Emmanuelle Leygues
Head of Corporate Marketing & Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Press - ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com

Investors - ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
ghislaine.gasparetto@seitosei-actifin.com